HC
SLGCW

Hourglass Capital’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Hourglass Capital’s Portfolio SLGCW Stock Details SLGCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38,000
Closed -$131K – 105
2021
Q3 		$131K Buy
+38,000
New +$117K 0.04% 101

Other funds holding SLGCW

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Hourglass Capital's SLGCW Position: Q4 2021 in Review

Hourglass Capital sold out of SomaLogic, Inc. Warrant (SLGCW) in Q4 2021, closing a stake of 38,000 shares — an estimated $131K sold.

Hourglass Capital first reported a position in SLGCW in Q3 2021 and held it in 1 quarter. The position peaked at $131K in Q3 2021. 34 funds tracked by Wall St. Rank hold SLGCW as of Q4 2021.

  • Hourglass Capital reported no remaining SomaLogic, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
  • Hourglass Capital sold 38,000 SomaLogic, Inc. Warrant shares in Q4 2021, an estimated $131K.
  • Hourglass Capital first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 1 quarter.
  • Hourglass Capital's SomaLogic, Inc. Warrant position peaked at $131K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q4 2021.

Based on Hourglass Capital's 13F filing for Q4 2021, filed 11 Feb 2022.